Akeso publishes ivonescimab Phase II study results in Nature Medicine
First patient dosed in Phase 1 trial of Transgene and BioInvent's BT-001 for rectal cancer
SK Biopharmaceuticals submits cenobamate supplemental New Drug Application to US FDA
Minghui Pharmaceutical licenses IGF-1R antibody to ASKA Pharmaceutical in Japan
WuXi Biologics receives two awards at 2026 HERA
CHOSA Oncology signs US laboratory agreement for Platin-DRP commercialisation
Agilent acquires Proscia for USD240m
BeOne Medicines wins FDA Priority Review for BRUKINSA combination in first-line mantle cell lymphoma
Sectra wins seven-year radiology reporting contract with Mount Sinai Health System
Pentixapharm advances preparationsfor Phase 3 PANDA study
ABIONYX Pharma partners with Lille University Hospital to explore CER-001 for severe burn patients
Samsung Biologics awarded 'Negligible Risk' rating in Sustainalytics ESG assessment
CStone and Kimia Therapeutics collaborate to advance oncology drug candidate